BioSpace News Archive

The collaborative study of regulatory-grade real world evidence in cardiovascular medicine demonstrates data and technologies to support high credibility clinical assertions

Velan Capital, L.P. (together with the other members of its group, “Velan” or “we”), one of the largest stockholders of Progenics Pharmaceuticals, Inc. (“Progenics” or the “Company”)(NASDAQ:PGNX), comprised of successful specialty pharmaceutical operators and financial services experts, today announced that it has filed a preliminary consent statement with the SEC and delivered a written consent to the Company seeking to reconstitute the Progenics Board of Directors

Holly Whitaker joins the second annual list of the women building America’s most inspiring businesses, along with Rebecca Minkoff, Serena Williams, Audrey Gelman, Rihanna, Alli Webb, and Eileen Fisher.

Voting was held online between April 1st and April 27th, 2019.

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research

MediSpend welcomes Diana Borges as vice president of compliance solutions and Françoise Renaud as vice president of client operations.

Their therapeutic programs enhance rehabilitation by building lifelong skill sets including emotional stability, resilience, independence, and health and wellness practices.

Khera will lead regulatory strategy and development services for the company’s sponsor clients across multiple therapeutic indications, clinical development stages and Worldwide’s expanding global clinical trial footprint.

Phase 2 clinical trial initiated and enrollment progressing across 24 sites

This market report provides a detailed analysis of the market by type (biologics and small molecules) and geography (Asia, Europe, North America, and ROW).